Vice President, Global Program Head - Immunology, Innovative Medicines

Who We Are:

Together, we’re on a mission to make good health more affordable and accessible, to help millions around the world enjoy healthier lives. It’s a mission that bonds our people across nearly 60 countries and a rich, diverse variety of nationalities and backgrounds. Working here means working with the world’s leading manufacturer of generic medicines, and the proud producer of many of the products on the World Health Organization’s Essential Medicines List.

Today, at least 200 million people around the world take one of our medicines every single day. An amazing number, but we’re always looking for new ways to continue making a difference, and new people to make a difference with.

The Opportunity:

The Vice President, Global Program Head (GPH) is an enterprise-level executive responsible for the end-to-end strategy, leadership, and delivery of the full portfolio within an assigned disease area, spanning multiple global programs from early development through regulatory approval and lifecycle management. The GPH serves as the strategic owner of the disease-area portfolio and its assigned assets, driving a forward-looking, transformative vision grounded in scientific excellence, commercial insight, and patient impact.

This role integrates scientific, clinical, regulatory, and commercial strategy to shape a differentiated portfolio, maximize asset value, and ensure successful progression throughout the product life cycle. The GPH leads multiple complex matrix global program teams (GPTs), anticipates future therapeutic, regulatory, and technological shifts, shapes stakeholder expectations, and ensures alignment across the full research–development–commercial spectrum.

Position Locations:
This is a hybrid position and can be based near of our hubs:
West Chester PA USA/Parsippany NJ USA, Netherlands, or Israel

Key Responsibilities:

Strategic Leadership & Enterprise Vision Set a bold, transformational asset vision anticipating future scientific, technological (e.g., AI, precision medicine), and market trends to increase program competitiveness.

Embraces accountability for strategic direction, value creation, integrated development planning, and long-term lifecycle management of the asset.

Synthesizes complex internal and external insights, including the external competitive landscape, to inform enterprise-level decisions and scenario planning, ensuring a future-ready strategy despite an ambiguous or evolving environment.

End-to-End Program Ownership & Delivery Owns full program lifecycle from preclinical stages through global approval and beyond, ensuring scientific rigor, regulatory readiness, and commercial differentiation.

Leads the Global Program Team (GPT) through major program governance interactions, including the Innovative Development Committee; and helps represent the asset internally and externally, including global health authorities, advisory boards, and corporate partners.

Develops a strong working relationship with all team members and functional area stakeholders.  Cultivates a high functioning partnership with the GPTD and with commercial co-leader (late phase development programs).Stakeholder Leadership & External Engagement Shapes and aligns stakeholder expectations through transparent, evidence-based communication and inclusive decision-making.

Builds and sustains trusted relationships with senior leaders, peers, team members, partners, external experts, and joint governance structures.

Global Program Team Leadership & Talent Development Leads and inspires multidisciplinary global program teams, driving high performance, accountability, and shared ownership of outcomes.

Fosters a “project first” approach within the GPT. Works closely with project team members, inspiring a…